325 related articles for article (PubMed ID: 12469168)
1. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ
Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856
[TBL] [Abstract][Full Text] [Related]
3. A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533.
Wozniak AJ; Moon J; Thomas CR; Kelly K; Mack PC; Gaspar LE; Raben D; Fitzgerald TJ; Pandya KJ; Gandara DR
Clin Lung Cancer; 2015 Sep; 16(5):340-7. PubMed ID: 25703100
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Choong NW; Mauer AM; Haraf DJ; Lester E; Hoffman PC; Kozloff M; Lin S; Dancey JE; Szeto L; Grushko T; Olopade OI; Salgia R; Vokes EE
J Thorac Oncol; 2008 Sep; 3(9):1003-11. PubMed ID: 18758303
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).
Hida N; Okamoto H; Misumi Y; Sato A; Ishii M; Kashizaki F; Shimokawa T; Shimizu T; Watanabe K
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1625-31. PubMed ID: 22565592
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer.
Horinouchi H; Sekine I; Sumi M; Noda K; Goto K; Mori K; Tamura T
Cancer Sci; 2013 Jan; 104(1):93-7. PubMed ID: 23004347
[TBL] [Abstract][Full Text] [Related]
7. Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.
Zhao Q; Wang Z; Huang W; Wang Q; Yu S; Zhou T; Han D; Wu Z; Gong H; Sun H; Zhang J; Wei Y; Li H; Zhang Z; Lin H; Li B
Oncotarget; 2016 Feb; 7(7):8422-31. PubMed ID: 26761213
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen.
Bearz A; Minatel E; Rumeileh IA; Borsatti E; Talamini R; Franchin G; Gobitti C; Del Conte A; Trovò M; Baresic T
BMC Cancer; 2013 Oct; 13():513. PubMed ID: 24176164
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.
Yao M; Galanopoulos N; Lavertu P; Fu P; Gibson M; Argiris A; Rezaee R; Zender C; Wasman J; Machtay M; Savvides P
Head Neck; 2015 Nov; 37(11):1665-71. PubMed ID: 24954745
[TBL] [Abstract][Full Text] [Related]
10. Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer.
Fuchs H; Pammer J; Minichsdorfer C; Posch D; Kornek G; Aretin MB; Fuereder T
Med Oncol; 2018 Feb; 35(3):32. PubMed ID: 29411154
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma.
Yao M; Woods C; Lavertu P; Fu P; Gibson M; Rezaee R; Zender C; Wasman J; Sharma N; Machtay M; Savvides P
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1770-6. PubMed ID: 26918562
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel in stage III and IV non-small cell lung cancer.
Rigas JR
Eur J Cancer; 1995; 31A Suppl 4():S18-20. PubMed ID: 7577100
[TBL] [Abstract][Full Text] [Related]
13. Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.
Gupta T; Agarwal JP; Ghosh-Laskar S; Parikh PM; D'Cruz AK; Dinshaw KA
Head Neck Oncol; 2009 Jun; 1():17. PubMed ID: 19527507
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.
Koukourakis MI; Giatromanolaki A; Kakolyris S; Froudarakis M; Georgoulias V; Retalis G; Bahlitzanakis N
Med Oncol; 2000 May; 17(2):135-43. PubMed ID: 10871820
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.
Gadgeel SM; Wozniak A; Ruckdeschel JC; Heilbrun LK; Venkatramanamoorthy R; Chaplen RA; Kraut MJ; Kalemkerian GP
J Thorac Oncol; 2008 Nov; 3(11):1293-300. PubMed ID: 18978565
[TBL] [Abstract][Full Text] [Related]
16. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Wu TC; Luterstein E; Neilsen BK; Goldman JW; Garon EB; Lee JM; Felix C; Cao M; Tenn SE; Low DA; Kupelian PA; Steinberg ML; Lee P
JAMA Oncol; 2024 Mar; 10(3):352-359. PubMed ID: 38206614
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of concomitant radiation and chemotherapy in patients with locally advanced head and neck cancer.
Tomio L; Zorat PL; Paccagnella A; Segati R; Loreggian L; Lora O; Friso ML; Chiarion-Sileni V; Favaretto A; Fede A
Am J Clin Oncol; 1993 Jun; 16(3):264-7. PubMed ID: 8338061
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups.
Schaake-Koning C; van den Bogaert W; Dalesio O; Festen J; Hoogenhout J; van Houtte P; Kirkpatrick A; Koolen M; Maat B; Nijs A
Lung Cancer; 1994 Mar; 10 Suppl 1():S263-70. PubMed ID: 8087519
[TBL] [Abstract][Full Text] [Related]
19. The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts.
Braakhuis BJ; Kegel A; Welters MJ
Cancer Lett; 1994 Jun; 81(2):151-4. PubMed ID: 7912164
[TBL] [Abstract][Full Text] [Related]
20. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial.
Bachaud JM; David JM; Boussin G; Daly N
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):243-6. PubMed ID: 1991685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
